MALAT1 and breast carcinoma: Similarly, using RNA-seq data and the clinical data from 1086 patients in the TCGA breast cancer cohort at cBioportal, Zheng et al. found a significant negative correlation between OS and the expression of MALAT1 in patients diagnosed at age below 60 or in patients with infiltrating ductal carcinoma [23].